The Mounjaro Dose Question Everyone Asks (Finally Answered)

Mounjaro at a glance:

• Drug class: Dual GIP / GLP-1 receptor agonist
• Manufacturer: Eli Lilly
• FDA approved: 2022
• Route: subcutaneous injection
• Typical frequency: once weekly
• Half-life: approximately 5 days
• Cash price (US): $1,000-$1,100/month without insurance
• Receptor target: GIP and GLP-1 receptors (dual)

Dosing Mounjaro correctly isn't complicated, but the details matter. The standard schedule is once weekly via subcutaneous injection, and the key decisions happen during titration.

Standard Dosing Schedule for Mounjaro

Mounjaro starts at 2.5 mg weekly (starting / non-therapeutic), then 5, 7.5, 10, 12.5, and up to 15 mg. Each step is held at least four weeks for tolerability.

The typical schedule for Mounjaro is once weekly via subcutaneous injection. Half-life of approximately 5 days explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For incretin therapies, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms (nausea, vomiting, diarrhea).

A typical titration plan for Mounjaro holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Mounjaro is missed: for weekly schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 5 days) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Mounjaro side effects and the cost angle of dose escalation in Mounjaro cost.

What the Trials Used

Published trial data for Mounjaro comes primarily from: SURPASS-2 (Frias 2021, NEJM) — superior A1c reduction and ~5 kg greater weight loss vs semaglutide 1 mg.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Mounjaro: the personal or family history of medullary thyroid carcinoma, MEN 2 syndrome apply.

Bottom Line

The single biggest dosing mistake we see with Mounjaro is impatience — skipping titration steps to get to the goal dose faster. It almost always backfires.

Frequently Asked Questions

Related Reading

• What Is Mounjaro? Everything You Should Know Before Starting
• Mounjaro Side Effects: 7 Things to Watch For (and How to Manage Them)
• Mounjaro Outcomes Decoded: Who Responds Best and Why
• Why Mounjaro Costs So Much (and 5 Ways to Pay Less)
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.
• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.
• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.